Effects of raloxifene on fracture risk in postmenopausal women: the Raloxifene Use for the Heart Trial.

@article{Ensrud2008EffectsOR,
  title={Effects of raloxifene on fracture risk in postmenopausal women: the Raloxifene Use for the Heart Trial.},
  author={Kristine E Ensrud and John L Stock and Elizabeth Barrett-Connor and Deborah Grady and Lori J Mosca and Kay-tee Khaw and Qingwen Zhao and Donato Agnusdei and Jane A. Cauley},
  journal={Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research},
  year={2008},
  volume={23 1},
  pages={112-20}
}
UNLABELLED Using data from a randomized placebo-controlled trial of 10,101 postmenopausal women not selected on the basis of osteoporosis, we examined whether the effect of raloxifene treatment on fractures was consistent across categories of fracture risk. Treatment with raloxifene for 5 yr reduced the risk of clinical vertebral fractures, but not… CONTINUE READING